Janssen

T/A Johnson & Johnson

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal.

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Learn more at https://www.jnj.com.

MSD

Astellas

Astellas is committed to creating innovative drugs with cutting-edge science that can address areas of high unmet medical needs. We aim to help patients who have no treatment options, or do not respond adequately to existing treatments.

We strive to improve and enhance quality throughout the product lifecycle, not only in drug discovery, development, production, and commercial but also in post-marketing surveillance, safety information collection, and our collaborative work with medical professionals. Astellas conducts business in more than 70 countries and regions around the world, and in addition to complying with each country and region’s laws, regulations, and guidelines, we have established a system where all employees engage in business activities with high ethical standards and a broad perspective.

EuroLab

In 2011, the establishment of Eurolab marked a significant step towards diminishing the financial burdens associated with cancer care in South Africa.

Our primary mission revolves around enhancing the accessibility and affordability of cancer care, catering to the needs of patients battling this disease. Through its progression, Eurolab has been able to expand and introduce innovation into South Africa’s cancer care environment offering diverse options for cancer treatment and recovery.

Eurolabs journey is far from over. We will continue to pursue innovative therapies and strategies aimed at introducing these into the South African market. Our unwavering commitment to maintaining a balance between cost-effectiveness and quality is what distinguishes us, ultimately making cancer treatment a more attainable reality for the larger population.

Prostate Cancer Foundation

The Prostate Cancer Foundation is unique in that it brings together the healthcare professionals who diagnose, treat and research prostate cancer; the men whose lives are affected by a diagnosis of prostate cancer; and the medical and pharmaceutical industry who provide the diagnostics and treatments for prostate cancer.

These 3 groups work together to improve clinical standards, raise awareness about prostate cancer, educate men about the disease and the available treatment options and to support men with prostate cancer and their families.

The Foundation is supported by donations, educational grants and corporate memberships. An annual awareness and fund-raising campaign called Suit Up September is run during September which is prostate cancer awareness month.

Dr Reddy's Oncology

Dr. Reddy's Laboratories is a global pharmaceutical company with a presence in 76 countries, known for its commitment to broadening access to quality, affordable generic medicine, biosimilars as well as innovative medicine.

Dr. Reddy’s portfolio will continue to expand annually to ensure more patients in South Africa gain access to required treatments. Our oncology portfolio includes, but is not limited to, treatments for some of the most prevalent cancers in South Africa.

By integrating advanced science and technology, we are committed to providing access to affordable and innovative medicines, driven by our purpose of ‘Good Health Can’t Wait’.

Acino

Acino Healthcare is a Swiss pharmaceutical company headquartered in Zurich, committed to developing, manufacturing, and internationally marketing high-quality, well-proven and innovative pharmaceuticals in high-growth markets.

Acino South Africa, managed from its regional office in Johannesburg, operates sales offices in Cape Town and Durban and is recognised as a Top Employer (2025) for the fourth consecutive year. The company holds a BBBEE Level 1 certification (2025) for the fifth consecutive year and is ranked among the leading private pharmaceutical companies in South Africa.

With a diverse and growing portfolio, Acino South Africa has a pipeline of approximately 50 products planned for launch* over the coming years.